Preclinical efficacy models and services to support early drug development, including patient-derived xenograft (PDX) models and in vitro/in silico translational approaches.

Genetic, acute to chronic toxicology, and safety pharmacology studies conducted in compliance with regulatory standards for pharmaceuticals, chemicals, and consumer products.